The Vision
The future of structural heart care begins before the hospital.
HUDDLE established feasibility. PREVUE quantified disease burden. VLOOP evaluates implementation at scale — and generates the evidence needed to expand nationally.
The Scientific Question VLOOP Answers
“Can we create a scalable, community-based pathway that identifies clinically actionable structural heart disease and reliably connects patients to specialty cardiovascular care?”
VLOOP is designed to answer this definitively — and to generate the evidence needed to expand nationally.
Beyond VLOOP
The 500-participant study is the beginning
Each phase of expansion unlocks the next level of impact.
500 Participants
VLOOP — proof of concept at scale.
Multi-State Expansion
2,000+ participants across The Arbor Company's full network.
National Registry
Implementation science database informing policy and payer strategy.
Earlier Detection → Earlier Intervention
Improved outcomes through timely structural heart therapy.
Our Vision
“We believe the future of structural heart care begins before patients arrive at the hospital.”
By integrating portable imaging, artificial intelligence, expert cardiology interpretation, and care navigation into one standardized workflow, VLOOP has the potential to redefine how older adults are identified, evaluated, and connected to specialty cardiovascular care.
This is more than an investigator-initiated study. It is the first step toward building a new national access pathway for structural heart disease.
Building the Future Together
We invite your partnership
In generating the evidence needed to transform community access to structural heart care.
“How can we work together to create a scalable, community-based pathway that reliably connects patients with structural heart disease to the care they need — before it is too late?”
Principal Investigator
Alexis K. Okoh, MD
Principal Investigator, G-ACT Foundation
Non-Invasive Cardiology, Northside Hospital Heart Institute
Emory University School of Public Health